Novel schizophrenia therapy filed for FDA approval
Nat Rev Drug Discov
.
2023 Nov;22(11):862.
doi: 10.1038/d41573-023-00164-z.
Author
Asher Mullard
PMID:
37803083
DOI:
10.1038/d41573-023-00164-z
No abstract available
Publication types
News
MeSH terms
Drug Approval
Humans
Schizophrenia* / drug therapy
United States
United States Food and Drug Administration